Dow Up 1.31% Nasdaq Up 2.40%

Vertex Pharmaceuticals Incorporated (VRTX)

-NasdaqGS
108.16 Up 3.39(3.24%) Oct 21, 4:00PM EDT
|After Hours : 109.55 Up 1.39 (1.29%) Oct 21, 7:59PM EDT
Prev Close:104.77
Open:105.86
Bid:109.50 x 100
Ask:110.50 x 100
1y Target Est:115.41
Beta:-0.97
Next Earnings Date:28-Oct-14VRTX Earnings announcement
Day's Range:104.51 - 110.91
52wk Range:58.06 - 116.88
Volume:1,897,317
Avg Vol (3m):1,658,840
Market Cap:25.75B
P/E (ttm):N/A
EPS (ttm):-2.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for VRTX

Comparison

Symbol% ChgMkt Cap
VRTXUp 3.24%25.75B
BMYUp 2.75%86.13B
MRKUp 2.00%159.03B
PTCTUp 0.91%1.11B

Key Statistics

Forward P/E (1 yr):1,081.60
P/S (ttm):30.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.86
Quarterly EPS Est (Sep-14) :-0.63
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-1.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback